Reply to S. Fuji.
作者信息
Levis Mark J, Hamadani Mehdi, Horowitz Mary M, Chen Yi-Bin
机构信息
Mark J. Levis, MD, PhD, Johns Hopkins University, Baltimore, MD; Mehdi Hamadani, MD and Mary M. Horowitz, MD, CIBMTR / Medical College of Wisconsin, Milwaukee, WI; and Yi-Bin Chen, MD, Massachusetts General Hospital, Boston, MA.
出版信息
J Clin Oncol. 2024 Nov 10;42(32):3881-3882. doi: 10.1200/JCO.24.01091. Epub 2024 Jul 31.
Abstract
摘要
相似文献
1
Reply to S. Fuji.回复藤井S。
J Clin Oncol. 2024 Nov 10;42(32):3881-3882. doi: 10.1200/JCO.24.01091. Epub 2024 Jul 31.
2
Reply to S. Fuji.
J Clin Oncol. 2020 Feb 10;38(5):523. doi: 10.1200/JCO.19.02689. Epub 2019 Dec 5.
3
Reply to S. Fuji.
J Clin Oncol. 2021 Apr 20;39(12):1412-1413. doi: 10.1200/JCO.20.02891. Epub 2021 Feb 23.
4
Comparison of the shear bond strength of 3D printed temporary bridges materials, on different types of resin cements and surface treatment.3D打印临时桥材料在不同类型树脂水门汀及表面处理下的剪切粘结强度比较
J Clin Exp Dent. 2019 Apr 1;11(4):e367-e372. doi: 10.4317/jced.55617. eCollection 2019 Apr.
5
FTIR investigation of polymerisation and polyacid neutralisation kinetics in resin-modified glass-ionomer dental cements.傅里叶变换红外光谱法对树脂改性玻璃离子水门汀聚合及多元酸中和动力学的研究
Biomaterials. 2002 Aug;23(15):3289-95. doi: 10.1016/s0142-9612(02)00092-3.
6
Physico-mechanical properties of a fast-set highly viscous GIC restorative.一种快速凝固的高粘性玻璃离子水门汀修复材料的物理机械性能
J Oral Rehabil. 2003 Jan;30(1):1-8. doi: 10.1046/j.1365-2842.2003.01006.x.
7
Reply to S. Fuji et al.
J Clin Oncol. 2014 Jun 10;32(17):1860-1. doi: 10.1200/JCO.2014.55.4048. Epub 2014 May 5.
8
Comparative Evaluation of the Antimicrobial Properties of Glass Ionomer Cements with and without Chlorhexidine Gluconate.含与不含葡萄糖酸氯己定的玻璃离子水门汀抗菌性能的比较评价
Int J Clin Pediatr Dent. 2016 Apr-Jun;9(2):99-103. doi: 10.5005/jp-journals-10005-1342. Epub 2016 Jun 15.
9
Fluoride release by glass ionomer cements, compomer and giomer.玻璃离子水门汀、复合体及聚酸改性复合树脂的氟释放
Dent Res J (Isfahan). 2009 Fall;6(2):75-81.
10
Genomic dissection of a 'Fuji' apple cultivar: re-sequencing, SNP marker development, definition of haplotypes, and QTL detection.‘富士’苹果品种的基因组剖析：重测序、SNP标记开发、单倍型定义及QTL检测
Breed Sci. 2016 Sep;66(4):499-515. doi: 10.1270/jsbbs.16018. Epub 2016 Jul 8.
本文引用的文献
1
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of .吉特替尼作为伴有. 内部串联重复突变的 AML 移植后维持治疗。
J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12.
2
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.吉特替尼联合诱导和巩固化疗及维持治疗：一项新诊断 AML 患者的 Ib 期研究。
J Clin Oncol. 2023 Sep 10;41(26):4236-4246. doi: 10.1200/JCO.22.02721. Epub 2023 Jun 28.
3
Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.吉特替尼的药代动力学特征：一种新型的 FLT-3 酪氨酸激酶抑制剂。
Clin Pharmacokinet. 2020 Oct;59(10):1273-1290. doi: 10.1007/s40262-020-00888-w.
Zotero 插件